Johnson & Johnson announced record sales of $16.5 billion for the second quarter of 2008, an increase of 8.7% as compared to the second quarter of 2007. Operational growth was 3.1% and the positive impact of currency was 5.6%. Domestic sales were up 2.1%, while international sales increased 16.2%.
"We are successfully managing through short-term pressures while continually making progress to enhance our long-term growth," said William C. Weldon, chairman and CEO, J&J.
Net earnings and diluted earnings per share for the second quarter of 2008 were $3.3 billion and $1.17, respectively. The company increased its earnings guidance for full-year 2008 to $4.45-$4.50 per share, which does not include the impact of any in-process research and development charges or other special items.